Venom Immunotherapy to Prevent Anaphylactic Shock

Immunotherapy of Hypersensitivity to Hymenoptera Venom is Reviewed
Immunotherapy Weekly, 12/28/05

Researchers review immunotherapy of hypersensitivity to hymenoptera venom in a recent issue of Expert Opinion on Biological Therapy.

"Insect sting allergy is a common condition with a risk of life-threatening anaphylaxis. After a severe reaction, the fear of being re-stung can significantly reduce quality of life. Venom immunotherapy (VIT) is a highly effective treatment of the underlying type I-sensitization. [Our] review addresses the mechanisms of immune modulation by VIT and outlines current clinical application," investigators in Germany report. . .

Roers and Hunzelmann published their review in Expert Opinion on Biological Therapy (Immunotherapy of hypersensitivity to hymenoptera venom. Expert Opin Biol Ther, 2005;5(10):1349-1358).

For additional information, contact Nicolas Hunzelmann, Department of Dermatology, University of Cologne, Josef-Stelzmann-Strasse 9, D-50931 Cologne, Germany. E-mail: Nicolas.hunzelmann@uni-koeln.de.

The publisher of the journal Expert Opinion on Biological Therapy can be contacted at: Ashley Publications Ltd., Telephone House, 69-77 Paul Street, London EC2A 4LQ, England.